Cargando…

Commentary: Serum Biomarkers Are Potential Diagnosis and Treatment Targets for Depressive Symptoms in Patients With Cardiovascular Diseases

Detalles Bibliográficos
Autores principales:	Liu, Cunming, Yang, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215195/ https://www.ncbi.nlm.nih.gov/pubmed/34163381 http://dx.doi.org/10.3389/fpsyt.2021.649705

Ejemplares similares

Commentary: Parental Depressive Symptoms as a Predictor of Outcome in the Treatment of Child Internalizing and Externalizing Problems
por: Tahir, Talha, et al.
Publicado: (2019)

Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Khan, Tauseef A., et al.
Publicado: (2021)

Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression
por: Yang, Xin-Jing, et al.
Publicado: (2022)

Serum Testosterone Levels and Symptom-Based Depression Subtypes in Men
por: Rodgers, Stephanie, et al.
Publicado: (2015)

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
por: Myint, Aye-Mu, et al.
Publicado: (2022)

Commentary: Determinants of quality of life and treatment satisfaction in dual-diagnosis patients
por: Wierdsma, André
Publicado: (2023)

Depression and the Link with Cardiovascular Disease
por: Dhar, Arup K., et al.
Publicado: (2016)

Serum Metabolic Profiling of Late-Pregnant Women With Antenatal Depressive Symptoms
por: Mao, Qiang, et al.
Publicado: (2021)

A Hypothesis of Gender Differences in Self-Reporting Symptom of Depression: Implications to Solve Under-Diagnosis and Under-Treatment of Depression in Males
por: Shi, Peixia, et al.
Publicado: (2021)

Potential Biomarkers for Predicting Depression in Diabetes Mellitus
por: Song, Xiuli, et al.
Publicado: (2021)

Common Brain Networks Between Major Depressive-Disorder Diagnosis and Symptoms of Depression That Are Validated for Independent Cohorts
por: Yamashita, Ayumu, et al.
Publicado: (2021)

Commentary: Sex Differences in the Peripheral Immune System in Patients with Depression
por: Breidenstein, Jonas, et al.
Publicado: (2017)

D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019)

The Relationship Between Serum Concentration of Vitamin D, Total Intracranial Volume, and Severity of Depressive Symptoms in Patients With Major Depressive Disorder
por: Zhu, Dao-min, et al.
Publicado: (2019)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
por: Myklebost, Sunniva Brurok, et al.
Publicado: (2022)

Response to: Commentary: Sex Differences in the Peripheral Immune System in Patients with Depression
por: Birur, Badari, et al.
Publicado: (2017)

Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
por: Sun, Xiao-Li, et al.
Publicado: (2023)

Persistent Depressive Symptoms and the Changes in Serum Cystatin C Levels in the Elderly: A Longitudinal Cohort Study
por: Han, Tiandong, et al.
Publicado: (2022)

Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms
por: Skule, Cecilie, et al.
Publicado: (2014)

Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study
por: Chou, Po-Han, et al.
Publicado: (2023)

Cardiovascular Disease Risk Factors Among Children and Adolescents With Depression
por: Korczak, Daphne J., et al.
Publicado: (2021)

Preoperative Serum Metabolites and Potential Biomarkers for Perioperative Cognitive Decline in Elderly Patients
por: Lu, Wenbin, et al.
Publicado: (2021)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

Commentary: “Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression”
por: Fried, Eiko I., et al.
Publicado: (2015)

Editorial: Sleep problems: diagnosis, biomarkers, interventions, and treatments
por: Jahrami, Haitham
Publicado: (2023)

Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Commentary: Evaluation of Models of Parkinson's Disease
por: Leal, Pollyana C., et al.
Publicado: (2016)

Neuropsychiatry in Demyelination Disease: Using Depression as a Prodrome for Early Diagnosis and Treatment of Multiple Sclerosis
por: Shail, Mrigank S
Publicado: (2017)

Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
por: Wells, Adrian, et al.
Publicado: (2022)

The Prevalence of Anxiety and Depressive Symptoms Among Patients With Celiac Disease in Jordan
por: Haj Ali, Sara, et al.
Publicado: (2023)

A Novel Network Pharmacology Strategy to Decode Metabolic Biomarkers and Targets Interactions for Depression
por: Gao, Yao, et al.
Publicado: (2020)

Altered Gamma-Band Activity as a Potential Biomarker for the Recurrence of Major Depressive Disorder
por: Yamamoto, Tetsuya, et al.
Publicado: (2018)

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
por: Nie, Li-Juan, et al.
Publicado: (2021)

Prediction model for potential depression using sex and age-reflected quantitative EEG biomarkers
por: Kim, Taehyoung, et al.
Publicado: (2022)

Quest for Biomarkers of Treatment-Resistant Depression: Shifting the Paradigm Toward Risk
por: Smith, Donald F.
Publicado: (2013)

Biological correlates of treatment resistant depression: a review of peripheral biomarkers
por: Mancuso, Emiliana, et al.
Publicado: (2023)

“Ready-to-use” two-week home exercise program targeting depressive symptoms: pilot study
por: Sandra, Dasha A., et al.
Publicado: (2023)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_div60nmp8svqdfi3bkvbd1m35b